血管活性肠肽（VIP）对先天性免疫反应的免疫调节作用：其在炎症性疾病中的治疗潜力
Immunomodulation of innate immune responses by vasoactive intestinal peptide (VIP): its therapeutic potential in inflammatory disease.
作者信息
Smalley S G R, Barrow P A, Foster N
机构信息
School of Veterinary Medicine and Science, University of Nottingham, Sutton Bonington Campus, Sutton Bonington, Leicestershire, UK.
出版信息
Clin Exp Immunol. 2009 Aug;157(2):225-34. doi: 10.1111/j.1365-2249.2009.03956.x.
Abstract
Since the late 1970s a number of laboratories have studied the role of vasoactive intestinal peptide (VIP) in inflammation and immunity. These studies have highlighted the dramatic effect of VIP on immune cell activation and function, and studies using animal models of disease have indicated that VIP has significant therapeutic and prophylactic potential. This review will focus on the effects of VIP on innate immune cell function and discuss the therapeutic potential for VIP in inflammatory diseases of humans.
摘要
自20世纪70年代末以来，许多实验室都在研究血管活性肠肽（VIP）在炎症和免疫中的作用。这些研究突出了VIP对免疫细胞激活和功能的显著影响，并且使用疾病动物模型的研究表明VIP具有重大的治疗和预防潜力。本综述将聚焦于VIP对固有免疫细胞功能的影响，并探讨VIP在人类炎症性疾病中的治疗潜力。
相似文献
1
Immunomodulation of innate immune responses by vasoactive intestinal peptide (VIP): its therapeutic potential in inflammatory disease.血管活性肠肽（VIP）对先天性免疫反应的免疫调节作用：其在炎症性疾病中的治疗潜力
Clin Exp Immunol. 2009 Aug;157(2):225-34. doi: 10.1111/j.1365-2249.2009.03956.x.
2
Editorial: vasoactive intestinal peptide (vip): historic perspective and future potential.社论：血管活性肠肽（VIP）：历史回顾与未来潜力
Endocr Metab Immune Disord Drug Targets. 2012 Dec;12(4):303-7. doi: 10.2174/187153012803832521.
3
Role of vasoactive intestinal peptide in inflammation and autoimmunity.血管活性肠肽在炎症和自身免疫中的作用。
Curr Opin Investig Drugs. 2005 Nov;6(11):1116-23.
4
The neuropeptide vasoactive intestinal peptide: direct effects on immune cells and involvement in inflammatory and autoimmune diseases.神经肽血管活性肠肽：对免疫细胞的直接作用以及在炎症和自身免疫性疾病中的参与情况。
Acta Physiol (Oxf). 2015 Feb;213(2):442-52. doi: 10.1111/apha.12427. Epub 2014 Dec 11.
5
Therapeutical approaches of vasoactive intestinal peptide as a pleiotropic immunomodulator.血管活性肠肽作为一种多效性免疫调节剂的治疗方法。
Curr Pharm Des. 2007;13(11):1113-39. doi: 10.2174/138161207780618966.
6
Vasoactive intestinal peptide: a neuropeptide with pleiotropic immune functions.血管活性肠肽：一种具有多种免疫功能的神经肽。
Amino Acids. 2013 Jul;45(1):25-39. doi: 10.1007/s00726-011-1184-8. Epub 2011 Dec 3.
7
VIP/PACAP oppositely affects immature and mature dendritic cell expression of CD80/CD86 and the stimulatory activity for CD4(+) T cells.血管活性肠肽/垂体腺苷酸环化酶激活肽对未成熟和成熟树突状细胞CD80/CD86的表达以及对CD4(+) T细胞的刺激活性具有相反的影响。
J Leukoc Biol. 2004 Jun;75(6):1122-30. doi: 10.1189/jlb.1203626. Epub 2004 Mar 12.
8
The significance of vasoactive intestinal peptide in immunomodulation.血管活性肠肽在免疫调节中的意义。
Pharmacol Rev. 2004 Jun;56(2):249-90. doi: 10.1124/pr.56.2.7.
9
Therapeutic potential of vasoactive intestinal peptide and its receptors in neurological disorders.血管活性肠肽及其受体在神经紊乱中的治疗潜力。
CNS Neurol Disord Drug Targets. 2010 Nov;9(5):661-6. doi: 10.2174/187152710793361595.
10
VIP in inflammatory bowel disease: state of the art.
Endocr Metab Immune Disord Drug Targets. 2012 Dec;12(4):316-22. doi: 10.2174/187153012803832576.
引用本文的文献
1
Ligands for Intestinal Intraepithelial T Lymphocytes in Health and Disease.健康与疾病状态下肠道上皮内T淋巴细胞的配体
Pathogens. 2025 Jan 23;14(2):109. doi: 10.3390/pathogens14020109.
2
Gene Expression Analysis Links Autocrine Vasoactive Intestinal Peptide and ZEB1 in Gastrointestinal Cancers.基因表达分析揭示胃肠癌中自分泌血管活性肠肽与ZEB1之间的联系
Cancers (Basel). 2023 Jun 22;15(13):3284. doi: 10.3390/cancers15133284.
3
Targeting vasoactive intestinal peptide-mediated signaling enhances response to immune checkpoint therapy in pancreatic ductal adenocarcinoma.靶向血管活性肠肽介导的信号传导可增强胰腺导管腺癌对免疫检查点疗法的反应。
Nat Commun. 2022 Oct 27;13(1):6418. doi: 10.1038/s41467-022-34242-4.
4
Immunomodulatory Role of Neuropeptides in the Cornea.神经肽在角膜中的免疫调节作用。
Biomedicines. 2022 Aug 16;10(8):1985. doi: 10.3390/biomedicines10081985.
5
Progress in the mechanism and targeted drug therapy for COPD.COPD 的发病机制及靶向药物治疗的研究进展。
Signal Transduct Target Ther. 2020 Oct 27;5(1):248. doi: 10.1038/s41392-020-00345-x.
6
Colonic delivery of vasoactive intestinal peptide nanomedicine alleviates colitis and shows promise as an oral capsule.肠道递送达肠活性肽纳米药物可缓解结肠炎，并有望成为口服胶囊。
Nanomedicine (Lond). 2020 Oct;15(25):2459-2474. doi: 10.2217/nnm-2020-0280. Epub 2020 Sep 25.
7
A Clinical Approach for the Use of VIP Axis in Inflammatory and Autoimmune Diseases.VIP 轴在炎症和自身免疫性疾病中的应用的临床方法。
Int J Mol Sci. 2019 Dec 20;21(1):65. doi: 10.3390/ijms21010065.
8
Development by Genetic Immunization of Monovalent Antibodies Against Human Vasoactive Intestinal Peptide Receptor 1 (VPAC1), New Innovative, and Versatile Tools to Study VPAC1 Receptor Function.通过基因免疫开发针对人血管活性肠肽受体1（VPAC1）的单价抗体，用于研究VPAC1受体功能的新型创新通用工具。
Front Endocrinol (Lausanne). 2018 Apr 5;9:153. doi: 10.3389/fendo.2018.00153. eCollection 2018.
9
Activation of VIP signaling enhances immunosuppressive effect of MDSCs on CMV-induced adaptive immunity.血管活性肠肽信号的激活增强了髓源性抑制细胞对巨细胞病毒诱导的适应性免疫的免疫抑制作用。
Oncotarget. 2017 Sep 7;8(47):81873-81879. doi: 10.18632/oncotarget.20704. eCollection 2017 Oct 10.
10
Neuroendocrine cells derived chemokine vasoactive intestinal polypeptide (VIP) in allergic diseases.神经内分泌细胞衍生趋化因子血管活性肠肽 (VIP) 在过敏性疾病中的作用。
Cytokine Growth Factor Rev. 2017 Dec;38:37-48. doi: 10.1016/j.cytogfr.2017.09.002. Epub 2017 Sep 23.
本文引用的文献
1
Inflammatory signals in dendritic cell activation and the induction of adaptive immunity.树突状细胞激活中的炎症信号与适应性免疫的诱导
Immunol Rev. 2009 Jan;227(1):234-47. doi: 10.1111/j.1600-065X.2008.00718.x.
2
Vasoactive intestinal peptide as a healing mediator in Crohn's disease.血管活性肠肽作为克罗恩病的愈合介质
Neuroimmunomodulation. 2008;15(1):46-53. doi: 10.1159/000135623. Epub 2008 Jul 29.
3
Receptors for secretin, calcitonin, parathyroid hormone (PTH)/PTH-related peptide, vasoactive intestinal peptide, glucagonlike peptide 1, growth hormone-releasing hormone, and glucagon belong to a newly discovered G-protein-linked receptor family.促胰液素、降钙素、甲状旁腺激素(PTH)/甲状旁腺激素相关肽、血管活性肠肽、胰高血糖素样肽 1、生长激素释放激素和胰高血糖素受体属于新发现的 G 蛋白偶联受体家族。
Trends Endocrinol Metab. 1993 Dec;4(10):309-14. doi: 10.1016/1043-2760(93)90071-l.
4
Genetic association of vasoactive intestinal peptide receptor with rheumatoid arthritis: altered expression and signal in immune cells.血管活性肠肽受体与类风湿关节炎的遗传关联：免疫细胞中表达和信号的改变
Arthritis Rheum. 2008 Apr;58(4):1010-9. doi: 10.1002/art.23482.
5
VIP balances innate and adaptive immune responses induced by specific stimulation of TLR2 and TLR4.血管活性肠肽（VIP）平衡由Toll样受体2（TLR2）和Toll样受体4（TLR4）的特异性刺激所诱导的先天性和适应性免疫反应。
Peptides. 2008 Jun;29(6):948-56. doi: 10.1016/j.peptides.2008.01.019. Epub 2008 Feb 7.
6
Vasoactive intestinal peptide suppresses toll-like receptor 4 expression in macrophages via Akt1 reducing their responsiveness to lipopolysaccharide.血管活性肠肽通过Akt1抑制巨噬细胞中Toll样受体4的表达，降低其对脂多糖的反应性。
Mol Immunol. 2008 May;45(10):2970-80. doi: 10.1016/j.molimm.2008.01.023. Epub 2008 Mar 11.
7
Inhalable liposomal formulation for vasoactive intestinal peptide.用于血管活性肠肽的可吸入脂质体制剂。
Int J Pharm. 2008 Jun 5;357(1-2):286-94. doi: 10.1016/j.ijpharm.2008.01.046. Epub 2008 Feb 3.
8
VIP differentially activates beta2 integrins, CR1, and matrix metalloproteinase-9 in human monocytes through cAMP/PKA, EPAC, and PI-3K signaling pathways via VIP receptor type 1 and FPRL1.血管活性肠肽（VIP）通过1型VIP受体和甲酰肽受体样1（FPRL1），经环磷酸腺苷/蛋白激酶A（cAMP/PKA）、交换蛋白直接激活cAMP的鸟苷酸交换因子（EPAC）和磷脂酰肌醇-3激酶（PI-3K）信号通路，差异性激活人单核细胞中的β2整合素、补体受体1（CR1）和基质金属蛋白酶-9。
J Leukoc Biol. 2008 Apr;83(4):972-81. doi: 10.1189/jlb.0507327. Epub 2008 Jan 16.
9
Neuropeptides activate human mast cell degranulation and chemokine production.神经肽可激活人类肥大细胞脱颗粒并促进趋化因子生成。
Immunology. 2008 Mar;123(3):398-410. doi: 10.1111/j.1365-2567.2007.02705.x. Epub 2007 Oct 6.
10
VIP inhibits P. gingivalis LPS-induced IL-18 and IL-18BPa in monocytes.血管活性肠肽抑制牙龈卟啉单胞菌脂多糖诱导单核细胞产生白细胞介素-18及白细胞介素-18结合蛋白a。
J Dent Res. 2007 Sep;86(9):883-7. doi: 10.1177/154405910708600915.
Zotero 插件